Tabimorelin hemifumarate structure
|
Common Name | Tabimorelin hemifumarate | ||
---|---|---|---|---|
CAS Number | 242143-80-2 | Molecular Weight | 586.72 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C32H40N4O3.1/2C4H4O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Tabimorelin hemifumarateTabimorelin (NN703) hemifumarate is an orally active growth hormone (GH) secretagogue. Tabimorelin hemifumarate is also a potent inhibitor of CYP3A4 activity[1]. |
Name | Tabimorelin hemifumarate |
---|---|
Synonym | More Synonyms |
Description | Tabimorelin (NN703) hemifumarate is an orally active growth hormone (GH) secretagogue. Tabimorelin hemifumarate is also a potent inhibitor of CYP3A4 activity[1]. |
---|---|
Related Catalog | |
Target |
CYP3A4 |
References |
Molecular Formula | C32H40N4O3.1/2C4H4O4 |
---|---|
Molecular Weight | 586.72 |
Exact Mass | 1172.630981 |
D-Phenylalaninamide, N-[(2E)-5-amino-5-methyl-1-oxo-2-hexen-1-yl]-N-methyl-3-(2-naphthalenyl)-D-alanyl-N,Nα-dimethyl-, (2E)-2-butenedioate (2:1) |
N-[(2E)-5-Amino-5-methyl-2-hexenoyl]-N-methyl-3-(2-naphthyl)-D-alanyl-N,Nα-dimethyl-D-phenylalaninamide (2E)-2-butenedioate (2:1) |
Tabimorelin |
N-[(2E)-5-Amino-5-methylhex-2-enoyl]-N-methyl-3-(2-naphthyl)-D-alanyl-N,Nα-dimethyl-D-phenylalaninamide (2E)-but-2-enedioate (2:1) |